Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To obtain further information on the tolerability of Atrovent® inhalets in the treatment of
Chronic Obstructive Airways Disease under conditions of daily practice